Kobayashi Pharmaceutical's Red Yeast Rice Controversy: Majority of Patients Found to Have Fanconi Syndrome, According to the Japanese Society of Nephrology

According to a report by MBS News on April 10th, the controversy surrounding Kobayashi Pharmaceutical's involvement in the "Red Yeast Rice" incident continues to escalate. The Japanese Society of Nephrology has revealed the results of their investigation on April 9th, indicating that the majority of patients who consumed Kobayashi Pharmaceutical's health products containing red yeast rice have developed Fanconi syndrome.

As of April 9th, a total of 212 consumers who took the red yeast rice-containing health products have been hospitalized, 1,224 individuals sought medical treatment, and there have been approximately 53,000 related inquiries. In order to investigate the matter, the Japanese Society of Nephrology collected samples of the problematic health products and conducted a detailed survey among 95 affected patients. The survey results showed that the majority of these patients indeed had Fanconi syndrome, a disorder affecting the function of the renal tubules. Their renal tubules exhibited abnormalities and were unable to properly reabsorb various substances required by the body, leading to the excretion of these substances.

The issue surrounding Kobayashi Pharmaceutical's health products has garnered significant attention, and the findings from the Japanese Society of Nephrology further intensify the focus on this incident. Relevant authorities are conducting a thorough investigation to determine the specific causes and implement appropriate measures. Consumers are urged to discontinue the use of these problematic health products and seek medical attention promptly if they experience related symptoms.

The progress of this matter is still under observation, and we will continue to provide the latest updates and reports.